Current filters:  
Poland
Healthcare
Food and Drugs Law
European Union
JWP Patent & Trademark Attorneys
Przemysł farmaceutyczny dzieli się na dwie kategorie wytwórców: firmy oryginalne i firmy generyczne.
JWP Patent & Trademark Attorneys
The pharmaceutical industry is divided into two categories of manufacturers: original drug companies and generics companies.
Poland
Hogan Lovells
In preparation for situations of crisis caused by a potential spread of the coronavirus, the Polish Parliament has adopted a draft bill that introduces certain new obligations upon...
Schoenherr Attorneys at Law
One year has passed since the Act on Counteracting the Unfair Use of Contractual Advantage in the Trade of Agricultural and Food Products entered into force.
Wierzbowski Eversheds Sutherland
The Act of 15 December 2016 on Counteracting Unfair Use of Contractual Advantage in Trade of Agricultural and Food Products came into force and effect on 12 July 2017.
Czyzewscy Kancelaria Adwokacka
The act will come into force 30 days after its publication in the Journal of Laws.
Schoenherr Attorneys at Law
On 12 July 2017, a new act on counteracting the unfair use of contractual advantage in trade in agricultural and food products (the "Act") will enter into force in Poland.
Global Advertising Lawyers Alliance (GALA)
The pharmaceutical market in Poland has significantly developed during the last decades making it attractive for investors.
CMS Cameron McKenna Nabarro Olswang LLP
Products which are not registered as medicines may not be advertised as having medicinal properties, according to a decision of the Chief Pharmaceutical Inspector.
CMS Cameron McKenna Nabarro Olswang LLP
From 1 January 2012, doctors will only be able to obtain a medicinal product sample for 2 years after first requesting it, and will be limited to a maximum of 4 samples per year.
CMS Cameron McKenna Nabarro Olswang LLP
New laws governing the reimbursement of medicines, medical devices and foodstuffs for special medical purposes have been signed by the President.
CMS Cameron McKenna Nabarro Olswang LLP
The Chief Pharmaceutical Inspector is entitled to supervise all pharmaceutical trade in Poland, including trade by companies based outside Poland, according to the Voivodship Administrative Court in Warsaw.
CMS Cameron McKenna Nabarro Olswang LLP
Significant proposed changes to pharmaceutical advertising are included in the ‘health pack’ currently being considered in Parliament.
CMS Cameron McKenna Nabarro Olswang LLP
The data exclusivity period applicable to pharmaceuticals for human use is to be extended by the introduction of an 8+2+1 rule to replace the current 6-year exclusivity period.
CMS Cameron McKenna Nabarro Olswang LLP
The procedures for setting prices and applying for reimbursement of pharmaceuticals and medical devices is to be fundamentally changed.
CMS Cameron McKenna Nabarro Olswang LLP
The European Commission has approved a PLN 40.5 million (c. €10 million) loan from Poland for the restructuring of Tarchominskie Zakłady Farmaceutyczne "POLFA" S.A.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media